Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance

医学 随机对照试验 清晰 临床试验 事件(粒子物理) 物理疗法 重症监护医学 外科 内科学 生物化学 化学 物理 量子力学
作者
John Gregson,D. R. Fraser Taylor,Ruth Owen,Timothy Collier,David J. Cohen,Stuart Pocock
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:151 (22): 1606-1619 被引量:14
标识
DOI:10.1161/circulationaha.124.070251
摘要

The win ratio is a method for analyzing a hierarchical composite outcome. It has been most widely used in randomized clinical trials (RCTs) in cardiovascular disease. We performed a review of cardiovascular RCTs using the win ratio published between January 2022 and July 2024. The aims were to summarize current use and to provide examples to illustrate effective use and communication. We identified 36 eligible RCTs, mainly in heart failure and ischemic heart disease. Intervention was pharmaceutical in 26, a procedure in 7, and treatment strategy in 3 trials. When outcomes were analyzed with both conventional composite end points or hierarchical analysis, the conclusions tended to be similar. The win ratio was often used to combine evidence from event outcomes and quantitative measures together in a hierarchical composite, as was done in 23 RCTs. It was also used to create a clinically more relevant measure in RCTs by recognizing the clinical priorities among event outcomes. Selected example RCTs illustrate how the clarity of win ratio findings can be improved by (1) complementing the win ratio (a relative measure) with the win difference, (2) identifying which components of a hierarchical composite drive the overall results, and (3) clearly prespecifying the outcomes and win ratio analysis to be used. We conclude with a set of recommendations for future use of hierarchical composite outcomes and the win ratio. When used wisely, the win ratio is a valuable tool in the analysis of RCTs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
共享精神的应助被科研通管家采纳,获得10
1秒前
云清发布了新的文献求助10
1秒前
1秒前
科目三的应助被科研通管家采纳,获得10
1秒前
杨欣霖发布了新的文献求助10
1秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1秒前
weeadas发布了新的文献求助10
1秒前
FashionBoy的应助被科研通管家采纳,获得10
1秒前
任我的应助被科研通管家采纳,获得30
2秒前
领导范儿的应助被科研通管家采纳,获得10
2秒前
怕黑成风发布了新的文献求助10
2秒前
英俊的铭的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
Hello的应助被科研通管家采纳,获得10
2秒前
赘婿的应助被科研通管家采纳,获得10
2秒前
ZC完成签到,获得积分10
2秒前
SciGPT的应助被仲松思采纳,获得10
2秒前
lilili的应助被科研通管家采纳,获得10
2秒前
3秒前
今后的应助被豌豆射手采纳,获得10
3秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
3秒前
surprise发布了新的文献求助10
3秒前
3秒前
深情安青的应助被科研通管家采纳,获得10
3秒前
充电宝的应助被科研通管家采纳,获得10
3秒前
慕青的应助被科研通管家采纳,获得10
3秒前
沉静的幼晴完成签到,获得积分10
3秒前
无私泥猴桃完成签到,获得积分10
3秒前
DW的应助被科研通管家采纳,获得10
3秒前
3秒前
英姑的应助被科研通管家采纳,获得10
3秒前
赘婿的应助被科研通管家采纳,获得10
4秒前
Sean发布了新的文献求助10
4秒前
4秒前
4秒前
Zhangyuanjie发布了新的文献求助10
4秒前
无极微光的应助被科研通管家采纳,获得20
4秒前
NexusExplorer的应助被科研通管家采纳,获得10
4秒前
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182706
求助须知:如何正确求助?哪些是违规求助? 9572086
关于积分的说明 21822405
捐赠科研通 7779207
什么是DOI,文献DOI怎么找? 3433702
关于科研通互助平台的介绍 2557891
邀请新用户注册赠送积分活动 2479787